Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

This publication has 23 references indexed in Scilit:

• Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer
  New England Journal of Medicine, 1999
• Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part II: Cause of Death Misclassification and the Recent Rise and Fall in Prostate Cancer Mortality
  JNCI Journal of the National Cancer Institute, 1999
• Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part III: Quantifying the Link Between Population Prostate-Specific Antigen Testing and Recent Declines in Prostate Cancer Mortality
  JNCI Journal of the National Cancer Institute, 1999
• Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels
  The Prostate, 1998
• Prostate carcinoma screening in the county of Tyrol, Austria
  Cancer, 1997
• Usefulness of the ratio free/total prostatespecific antigen in addition to total PSA levels in prostate cancer screening
  Urology, 1996
• Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: Results of a large screening study
  Urology, 1995
• Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges
  JAMA, 1993
• Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
  New England Journal of Medicine, 1991
• TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMES
  The Lancet, 1987